Indications and uses
relieves occasional constipation (irregularity) generally produces a bowel movement in 6- 12 hours.
relieves occasional constipation (irregularity) generally produces a bowel movement in 6- 12 hours.
take preferably at bedtime or as directed by a doctor age starting dosage maximum dosage adults and children 12 years of age and over 2 tablets once a day 4 tablets twice a day children 6 to under 12 years 1 tablet once a day 2 tablets twice a day children 2 to under 6 years 1/2 tablets once a day 1 tablet twice a day children under 2 years ask a doctor ask a doctor
each tablet contains: calcium 30 mg store at 25 o C (77 o F); excursions permitted between 15-30ºC (59-86ºF)
Sennosides 8.6 mg
Laxative
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
| age | starting dosage | maximum dosage |
| adults and children 12 years of age and over | 2 tablets once a day | 4 tablets twice a day |
| children 6 to under 12 years | 1 tablet once a day | 2 tablets twice a day |
| children 2 to under 6 years | 1/2 tablets once a day | 1 tablet twice a day |
| children under 2 years | ask a doctor | ask a doctor |
croscarmellose sodium, dibasic calcium phosphate dihydrate, hypromellose, magnesium stearate, microcrystalline cellulose, mineral oil*, silicon dioxide*, stearic acid*, sodium lauryl sulfate*, talc*, triacetin*
*contains one or more of these ingredients
Call 1-877-753-3935 Monday-Friday 9AM-5PM EST
Senna Laxative
Standardized Senna Concentrate 8.6 mg
Natural Vegetable Laxative Ingredient
†Compare to active ingredients in Senokot®
Tablets
†This product is not manufactured or distributed by Aviro Health L.P., distributor of Senokot®.
TAMPER EVIDENT: DO NOT USE IF PRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING
KEEP OUTER CARTON FOR COMPLETE WARNINGS AND PRODUCT INFORMATION.
Distributed By:
Geiss, Destin & Dunn, Inc.
Peachtree City, GA 30269
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50804-631-10 | 2020-11-04 | C162847 | 48780-1 | ab0e2407-32f2-f274-e053-dbdaa90a6471 | Drug Facts |
| 50804-631-10 | 2020-09-27 | C162847 | 48780-1 | ab0e2407-32f2-f274-e053-dbdaa90a6471 | Drug Facts |
| 50804-631-10 | 2020-09-25 | C162847 | 48780-1 | ab0e2407-32f2-f274-e053-dbdaa90a6471 | Drug Facts |
| 50804-631-10 | 2020-07-22 | C162847 | 48780-1 | ab0e2407-32f2-f274-e053-dbdaa90a6471 | Drug Facts |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50804-631-10 | EA - Each | 50804-631 | ff068244-9ab6-40a2-b739-c9e9558ab43b | 1 | 2020-07-13 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 50804-631 | 50804-631-10 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SENNOSIDES | 3FYP5M0IJX | ACTIB |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | O7TSZ97GEP | IACT |
| HYPROMELLOSES | 3NXW29V3WO | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| MINERAL OIL | T5L8T28FGP | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
| TALC | 7SEV7J4R1U | IACT |
| SODIUM LAURYL SULFATE | 368GB5141J | IACT |
| TRIACETIN | XHX3C3X673 | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| fc4faf21-1ae8-4e87-9ed2-f41c91e8d691 | dfe2da8d-7678-45fa-9661-00a12a358fd4 | 2022-10-28 | Warnings | fc4faf21-1ae8-4e87-9ed2-f41c91e8d691 dfe2da8d-7678-45fa-9661-00a12a358fd4 |
Adverse event summaries are temporarily unavailable. Other product information remains available.